CW 2020 Annual Report

• changes in expectations as to our future financial performance, including financial estimates by securities analysts and investors; • strategic actions by us or our competitors; • announcements by us, our competitors or our vendors of significant contracts, acquisitions, joint marketing relationships, joint ventures or capital commitments; • changes in business or regulatory conditions; • investor perceptions or the investment opportunity associated with our ordinary shares relative to other investment alternatives; • the public’s response to press releases or other public announcements by us or third parties, including our filings with the SEC; • guidance, if any, that we provide to the public, any changes in this guidance or our failure to meet this guidance; • changes in accounting principles; • announcements by third parties or governmental entities of significant claims or proceedings against us; • a default under the agreements governing our indebtedness; • future sales of our ordinary shares by us, directors, executives and significant shareholders; • changes in domestic and international economic and political conditions and regionally in our markets; and • other events or factors, including those resulting from natural disasters, war, acts of terrorism or responses to these events. Furthermore, the stock market has from time to time experienced extreme volatility that, in some cases, has been unrelated or disproportionate to the operating performance of particular companies. These broad market and industry fluctuations may adversely affect the market price of our ordinary shares, regardless of our actual operating performance. As a result, our ordinary shares may trade at a price significantly below the price at which any shareholder purchased his or her ordinary shares. In the past, following periods of market volatility, shareholders have instituted securities class action litigation. If we were involved in securities litigation, it could have a substantial cost and divert resources and the attention of executive management from our business regardless of the outcome of such litigation. If we or our existing investors sell additional ordinary shares, the market price of our ordinary shares could decline. The market price of our ordinary shares could decline as a result of sales of a large number of ordinary shares in the market, or the perception that such sales could occur. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. As of December 31, 2020, we had 222.0 million ordinary shares outstanding. Of these outstanding ordinary shares, all of the ordinary shares sold in the IPO are freely tradable in the public market. All of our ordinary shares outstanding prior to the closing of the IPO, other than those sold in registered public offerings, and all of the ordinary shares sold in the private placement that closed concurrently with our IPO (the “Concurrent Private Placement”) are restricted securities as defined in Rule 144 under the Securities Act (“Rule 144”) and may be sold by the holders into the public market from time to time in accordance with and subject to Rule 144, including, where applicable, limitation on sales by affiliates under Rule 144. Refer to Note 1: Organization and Business Overview of our Consolidated Financial Statements for additional information on the Concurrent Private Placement.

25